Target Price Playground

Templates Custom Builder LEAP Simulator
LIN
$489.95
🟢
LIN IV: 23.4% — LOW (-47.1% vs 30d avg of 44.3%)
Options are cheap vs 30d avg — good time to BUY options (long calls/puts, debit spreads).
Forward Projection If price hits $530 by Dec 18
Historical Backtest Coming soon
Signal Backtest Coming soon

📋 Strategy

Own stock, sell OTM call for income. Caps upside.

🎯 Target

72d from today

⚙️ Legs

LONG 100 SHARES
@ $489.95 · Δ 1.00
SHORT CALL · $530 · Dec '26
Qty 1 · Premium $7.3 · Δ 0.26
P&L at Expiry Now $490 Target $530 $343 $490 $637
Stock (100 sh) Covered Call Now Target
💡 Stock vs Options at Target

If LIN hits $530 by Dec 18: the covered call returns +$4,735 (9.8%) on $48,265 risked, vs +$4,005 (8.2%) for 100 shares on $48,995. Options give 1.2× capital efficiency.

📅 Expiry

Options expire Dec 18, 2026 (72 days out). P&L shown is the value at expiry if LIN is at $530. Use the 30d / 60d / 90d / 180d pills to compare different expiries.

📊 Projected Return

P&L if LIN hits $530 by Dec 18
+$4,735
+9.8% on $48,265 risked
Max Profit
+$4,735
If the stock ≥ $530 at expiry
Max Loss
−$48,265
If stock → $0 (minus premium received)
Break-even
$482.65
-1.49% from spot
Prob. of Target Hit
44%
IV-implied, 72d (rough)
Net Δ / Θ / V
74.18 / 12.05 / -62.32
per spread, per $1 move / day / vol pt
💾 Log in to save 📊 My Saved Strategies

📋 Notes for each mode (not shown on real page)

Forward Projection
Reprices legs at (target_price, target_date) via Black-Scholes. Works on existing BS service. Simplest mode — ship first.
Historical Backtest
Uses our historical options chains to replay this exact strategy over past expirations. Needs: date picker, "rolling every N days", cumulative P&L chart.
Signal Backtest
"Run this strategy on every BUY-rated stock with score ≥ 80 for last 90d." Reuses score_backtest pipeline + strategy overlay.
Solve for Return
Inverse: user says "+50% in 90d", system solves for required price move, shows IV-implied probability. Pure math.

📊 P&L Scenarios — what happens at different prices and dates

LIN Price Today Oct 31 Nov 24 Dec 18 (exp)
$392 (-20%) -$9,073 -$9,069 -$9,069 -$9,069
$416 (-15%) -$6,643 -$6,623 -$6,619 -$6,619
$441 (-10%) -$4,272 -$4,199 -$4,171 -$4,170
$465 (-5%) -$2,044 -$1,863 -$1,740 -$1,720
$480 (-2%) -$828 -$559 -$325 -$250
$490 (0%) ← spot -$84 +$245 +$571 +$730
$500 (+2%) +$598 +$983 +$1,406 +$1,710
$514 (+5%) +$1,496 +$1,947 +$2,493 +$3,180
$530 (+8%) ← target +$2,276 +$2,761 +$3,371 +$4,735
$539 (+10%) +$2,647 +$3,135 +$3,742 +$4,735
$563 (+15%) +$3,399 +$3,839 +$4,330 +$4,735
$588 (+20%) +$3,840 +$4,193 +$4,524 +$4,735
Uses LIN's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.